What is it about?
Demonstrates that kidneys can be transplanted across incompatible bood groups without giving patients extra anti-rejection therapy. Only additional necessary treatment is removing the antibody shortly before and after the transplant.
Featured Image
Why is it important?
Makes it safer. We achieved results the same as for our standard kidney transplant patients and without the complications reported by many.
Read the Original
This page is a summary of: ABO-INCOMPATIBLE RENAL TRANSPLANTATION WITHOUT SPLENECTOMY OR RITUXIMAB – A LOW RATE OF COMPLICATIONS, Transplantation, July 2008, Wolters Kluwer Health,
DOI: 10.1097/01.tp.0000330967.09342.85.
You can read the full text:
Contributors
The following have contributed to this page